Controversies in antiplatelet therapy in the secondary prevention of stroke
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F16%3AN0000072" target="_blank" >RIV/00064190:_____/16:N0000072 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.eurger.2015.12.007" target="_blank" >http://dx.doi.org/10.1016/j.eurger.2015.12.007</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.eurger.2015.12.007" target="_blank" >10.1016/j.eurger.2015.12.007</a>
Alternative languages
Result language
angličtina
Original language name
Controversies in antiplatelet therapy in the secondary prevention of stroke
Original language description
Recurrence of stroke has been estimated at 3-4% yearly after TIA or stroke. There is no clear agreement in choosing antiplatelet therapy at this time. Europeans, Americans and British guidelines have been different. Aspirin is still used in secondary prevention of ischemic stroke, because of the longest experience with the best-achieved results in different studies and low price. Other used drugs are a combination of aspirin and dipyridamole, P2Y12 receptor antagonists - clopidogrel, ticlopidine, prasugrel and ticagrelor, or inhibitor of phosphodiesterase cilostazol, which was effective with Chinese and Japanese population. The common agreement is not to use a dual antiplatelet therapy in long term, because it does not carry a higher reduction of ischemic attacks than monotherapy. The other negative effect is causing more incidents with severe hemorrhage. According to the American recommendation, the combined therapy is promising early after having TIA and light stroke when the risk of recurrence of stroke is high.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FP - Other medical fields
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
EUROPEAN GERIATRIC MEDICINE
ISSN
1878-7649
e-ISSN
—
Volume of the periodical
7
Issue of the periodical within the volume
1
Country of publishing house
IT - ITALY
Number of pages
4
Pages from-to
65-69
UT code for WoS article
000369751600015
EID of the result in the Scopus database
2-s2.0-84958114566